Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine | MicrobiomeTrials← Back to trialsNCT05850091
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2023-12-07Est. Completion: 2027-06-01
Enrollment target: 200 participants Locations- Massachusetts General Hospital, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
Pulmonary Hypertension
Study Description:
This study aims to establish a biorepository based on the World Symposium Pulmonary Hypertension (PH…
Baltimore, United StatesEst. completion Jun 1, 2036
Perimenopause
Women's blood vessel health gets worse after menopause, or "the change of life". Some women exercise less during menopau…
Ann Arbor, United StatesEst. completion Dec 2026
Sickle Cell Disease
The collection of human specimens from both patients and healthy volunteers is necessary for the development of laborato…